CMEC 47th meeting, 13 August 2004
Complementary Medicines Evaluation Committee
Extracted ratified minutes
CMEC Meeting 47 extracted ratified minutes (pdf,76kb)
Public recommendation summary
This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.
Item 2 Minutes of CMEC's 46th meeting
Recommendation 47.1
CMEC confirms that the draft Minutes of its previous meeting (CMEC 46, 11 June 2004), as amended, are a true and accurate record of that previous meeting.
Item 6.1 Application for the evaluation of a new substance - Digestive enzymes: amylase, tilactase, protease derived from Aspergillus oryzae; cellulase derived from Trichoderma longibrachiatum; and lipase derived from Rhizopus oryzae
Recommendation 47.5
CMEC recommends to the TGA that the following enzymes:
- amylase, tilactase, protease derived from Aspergillus oryzae;
- cellulase derived from Trichoderma longibrachiatum;
- and lipase derived from Rhizopus oryzae
are suitable for use as active ingredients in Listed medicines.
Item 10.6 Matters referred from within TGA: Curcumin
Recommendation 47.8
CMEC notes the proposal by the Office of Complementary Medicines to permit the use of curcumin as an active ingredient in Listed medicines.